Please login to the form below

Not currently logged in
Email:
Password:

Inovio Biomedical elects new Board members

Inovio Biomedical Corporation has announced the election of David J Williams and Keith H Wells to its Board

DNA vaccine design, development and delivery firm Inovio Biomedical Corporation has announced the election of David J Williams, former chairman and CEO of Sanofi Pasteur, and Keith H Wells, a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute, to its Board. 

Dr J Joseph Kim, president and CEO of Inovio, said: "These two business leaders each have multiple decades of experience leading and executing the development and commercialisation of cutting-edge vaccine technology and important new vaccines. Their expertise will be invaluable to Inovio as we advance a new generation of vaccines – DNA vaccines delivered using the potency-enhancing capabilities of electroporation – that are displaying superior results and potential to not only prevent but treat challenging infectious diseases and cancers."

26th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics